Article Details
Retrieved on: 2024-12-16 18:15:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The alternative investment arm of Goldman Sachs said Monday that it plans to buy a majority stake in the drugmaker Synthon from British investment ...
Article found on: www.law360.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here